OSSIO’s new approach to bunionectomy features beveled threaded trimmable fixation nails and streamlined instrument set to ensure perfect fit for each patient’s bio-integrative, metal-free repair
OSSIOfiber, part of OSSIO Inc., a medical technology company advancing orthopedic surgery with bio-integrative, metal-free implants, has introduced its Minimally Invasive All-Natural (MIA) Bunion Correction System. The new system is designed to simplify bunionectomy procedures for both surgeons and patients while expanding OSSIO’s presence in the fast-growing orthopedic surgery market. The system features a metal-free, bio-integrative implant that gradually becomes part of the patient’s natural bone as healing occurs, leaving a stable, restored structure without permanent hardware.
Health Technology Insights: Corus Orthodontists Secures C$20 Million Equity Investment
The OSSIOfiber MIA Bunion Correction System uses a 4.5x70mm beveled threaded trimmable fixation nail. Like other OSSIOfiber implants, the nail completes its function over about two years and then integrates fully into the bone, eliminating the need for removal surgeries. The system also includes an efficient instrument set that allows surgeons to trim and customize the implant intraoperatively for each patient’s anatomy. The system was showcased at the annual American College of Foot and Ankle Surgery (ACFAS) conference in Las Vegas.
Dr. Steven K. Neufeld, founder of the Orthopaedic Foot & Ankle Center in Falls Church, Virginia, performed one of the first procedures using the new OSSIOfiber system. Dr. Neufeld, who specializes in minimally invasive foot and ankle surgery, said, “For my patients who require bunion correction, I use the OSSIOfiber MIA Bunion Correction System. This approach represents a major advancement in minimally invasive, bio-integrative bunion repair and elevates surgical outcomes.” Dr. Neufeld published the first U.S.-based study on minimally invasive bunion surgery in 2021 and recently presented a case series evaluating OSSIOfiber implants at the MIFAS 7th International Conference in 2025.
Clinical results from OSSIOfiber MIA procedures on eighteen patients, with an average age of sixty, demonstrated significant correction and rapid recovery. Patients returned to normal activities within six weeks, achieved full bone union by 26 weeks, and required no hardware removal or revision surgery. The bio-integrative implants reduced the risk of complications associated with traditional metal hardware while supporting natural bone healing.
Health Technology Insights: Steven Gonzalez on Leadership Presence and Future of Work
The OSSIOfiber threaded trimmable fixation nails are indicated for maintaining alignment and fixation in fractures, osteotomies, arthrodesis, and bone grafts across the upper extremity, fibula, knee, ankle, and foot in adults, children, and adolescents with closed or unaffected growth plates.
Brian Verrier, CEO of OSSIO, explained, “The MIA system is designed so the patient’s bunion is corrected and the implant gradually disappears through bio-integration. Patients regain their natural anatomy and return to full activity without any permanent metal in their body. This represents a true transformation in how bunion surgery is performed and experienced, setting a new standard for patient-centered orthopedic care.”
According to MedlinePlus, a bunion or hallux valgus is a bony bump that forms at the base of the big toe, often causing pain, stiffness, and swelling. Bunions develop over time and are a common foot disorder affecting roughly one-third of U.S. adults. They are more prevalent in women and increase in frequency with age due to factors such as footwear choices, foot anatomy, and genetics. The OSSIOfiber MIA system provides a modern, minimally invasive option for patients seeking effective bunion correction while preserving natural anatomy and minimizing long-term complications.
Health Technology Insights: Lōkahi Therapeutics Welcomes UGA Fellows to ai² Futures Lab
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
